Central Trust Company’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.77M | Buy |
19,885
+122
| +0.6% | +$17.1K | 0.05% | 213 |
|
|
2025
Q4 | $2.43M | Buy |
19,763
+249
| +1% | +$30.3K | 0.05% | 224 |
|
|
2025
Q3 | $2.17M | Buy |
19,514
+35
| +0.2% | +$3.98K | 0.05% | 248 |
|
|
2025
Q2 | $2.16M | Sell |
19,479
-400
| -2% | -$42.6K | 0.05% | 232 |
|
|
2025
Q1 | $2.23M | Sell |
19,879
-45
| -0.2% | -$4.64K | 0.05% | 223 |
|
|
2024
Q4 | $1.84M | Buy |
19,924
+33
| +0.2% | +$2.97K | 0.05% | 252 |
|
|
2024
Q3 | $1.67M | Sell |
19,891
-2,566
| -11% | -$196K | 0.04% | 257 |
|
|
2024
Q2 | $1.54M | Sell |
22,457
-70
| -0.3% | -$4.67K | 0.04% | 265 |
|
|
2024
Q1 | $1.65M | Sell |
22,527
-1,044
| -4% | -$80.3K | 0.04% | 258 |
|
|
2023
Q4 | $1.91M | Sell |
23,571
-294
| -1% | -$22.9K | 0.05% | 228 |
|
|
2023
Q3 | $1.79M | Sell |
23,865
-212
| -0.9% | -$16.3K | 0.05% | 227 |
|
|
2023
Q2 | $1.86M | Sell |
24,077
-2,713
| -10% | -$216K | 0.05% | 226 |
|
|
2023
Q1 | $2.22M | Sell |
26,790
-416
| -2% | -$34.5K | 0.07% | 210 |
|
|
2022
Q4 | $2.34M | Sell |
27,206
-188
| -0.7% | -$14.9K | 0.07% | 207 |
|
|
2022
Q3 | $1.69M | Buy |
27,394
+3,210
| +13% | +$202K | 0.06% | 219 |
|
|
2022
Q2 | $1.5M | Sell |
24,184
-9
| -0% | -$557 | 0.05% | 251 |
|
|
2022
Q1 | $1.44M | Sell |
24,193
-1,326
| -5% | -$84.8K | 0.04% | 273 |
|
|
2021
Q4 | $1.85M | Buy |
25,519
+577
| +2% | +$39.7K | 0.05% | 255 |
|
|
2021
Q3 | $1.74M | Buy |
24,942
+998
| +4% | +$70.1K | 0.06% | 236 |
|
|
2021
Q2 | $1.65M | Sell |
23,944
-1,065
| -4% | -$71.1K | 0.06% | 244 |
|
|
2021
Q1 | $1.62M | Buy |
25,009
+540
| +2% | +$34.8K | 0.06% | 230 |
|
|
2020
Q4 | $1.43M | Sell |
24,469
-34,306
| -58% | -$2.07M | 0.06% | 233 |
|
|
2020
Q3 | $3.71M | Sell |
58,775
-6,370
| -10% | -$442K | 0.17% | 114 |
|
|
2020
Q2 | $5.01M | Buy |
65,145
+9,603
| +17% | +$736K | 0.25% | 88 |
|
|
2020
Q1 | $4.15M | Buy |
55,542
+25,326
| +84% | +$1.75M | 0.25% | 89 |
|
|
2019
Q4 | $1.96M | Buy |
30,216
+2,440
| +9% | +$159K | 0.1% | 170 |
|
|
2019
Q3 | $1.76M | Buy |
27,776
+419
| +2% | +$27.4K | 0.1% | 173 |
|
|
2019
Q2 | $1.81M | Sell |
27,357
-398
| -1% | -$26.2K | 0.1% | 170 |
|
|
2019
Q1 | $1.8M | Sell |
27,755
-1,040
| -4% | -$69.1K | 0.11% | 164 |
|
|
2018
Q4 | $1.8M | Sell |
28,795
-274
| -0.9% | -$19.2K | 0.12% | 157 |
|
|
2018
Q3 | $2.25M | Sell |
29,069
-25,118
| -46% | -$1.9M | 0.13% | 155 |
|
|
2018
Q2 | $3.84M | Sell |
54,187
-5,484
| -9% | -$387K | 0.24% | 97 |
|
|
2018
Q1 | $4.5M | Sell |
59,671
-10,893
| -15% | -$866K | 0.29% | 85 |
|
|
2017
Q4 | $5.05M | Sell |
70,564
-852
| -1% | -$64.7K | 0.31% | 79 |
|
|
2017
Q3 | $5.79M | Sell |
71,416
-6,552
| -8% | -$501K | 0.37% | 66 |
|
|
2017
Q2 | $5.52M | Sell |
77,968
-8,939
| -10% | -$595K | 0.36% | 72 |
|
|
2017
Q1 | $5.9M | Sell |
86,907
-15,927
| -15% | -$1.12M | 0.39% | 69 |
|
|
2016
Q4 | $7.36M | Sell |
102,834
-8,356
| -8% | -$621K | 0.51% | 51 |
|
|
2016
Q3 | $8.8M | Sell |
111,190
-4,779
| -4% | -$388K | 0.64% | 37 |
|
|
2016
Q2 | $9.67M | Sell |
115,969
-2,279
| -2% | -$202K | 0.72% | 32 |
|
|
2016
Q1 | $10.9M | Sell |
118,248
-12,333
| -9% | -$1.11M | 0.86% | 26 |
|
|
2015
Q4 | $13.2M | Sell |
130,581
-2,111
| -2% | -$220K | 1.09% | 18 |
|
|
2015
Q3 | $13M | Buy |
132,692
+8,426
| +7% | +$936K | 1.13% | 15 |
|
|
2015
Q2 | $14.5M | Buy |
124,266
+2,981
| +2% | +$326K | 1.14% | 15 |
|
|
2015
Q1 | $11.9M | Sell |
121,285
-11,657
| -9% | -$1.18M | 0.96% | 22 |
|
|
2014
Q4 | $12.5M | Sell |
132,942
-1,175
| -0.9% | -$122K | 1.02% | 22 |
|
|
2014
Q3 | $14.3M | Buy |
134,117
+2,470
| +2% | +$242K | 1.13% | 19 |
|
|
2014
Q2 | $10.9M | Buy |
131,647
+2,974
| +2% | +$231K | 0.86% | 24 |
|
|
2014
Q1 | $9.12M | Buy |
128,673
+11,294
| +10% | +$886K | 0.75% | 30 |
|
|
2013
Q4 | $8.81M | Buy |
117,379
+2,569
| +2% | +$179K | 0.74% | 32 |
|
|
2013
Q3 | $7.22M | Sell |
114,810
-964
| -0.8% | -$57.6K | 0.65% | 38 |
|
|
2013
Q2 | $5.93M | Buy |
+115,774
| New | +$6.03M | 0.56% | 45 |
|
Other funds holding GILD
VCM
VPM
Central Trust Company's GILD Position: Q1 2026 in Review
Central Trust Company increased its Gilead Sciences (GILD) stake by 0.62% in Q1 2026, buying an estimated $17.1K and bringing the position to 19,885 shares worth $2.77M. The position accounts for 0.05% of the portfolio, ranked #213.
Central Trust Company first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.5M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Central Trust Company held 19,885 shares of Gilead Sciences worth $2.77M as of Q1 2026.
- Central Trust Company bought 122 Gilead Sciences shares in Q1 2026, an estimated $17.1K.
- Gilead Sciences made up 0.05% of Central Trust Company's portfolio in Q1 2026, its #213 holding.
- Central Trust Company first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Central Trust Company's Gilead Sciences position peaked at $14.5M in Q2 2015.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.